Open AccessJournal Article
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Shaul G. Massry,Jack W. Coburn,Glenn M. Chertow,Keith A. Hruska,Craig B. Langman,Hartmut H. Malluche,Kevin J. Martin,Linda McCann,James T. McCarthy,Sharon M. Moe,Isidro B. Salusky,Donald J. Sherrand,Miroslaw Smogorzewski,Kline Bolton,Charles Turkelson,Karyn A. Tappe,Stephen Tregear,James Reston,Wendy Bruening,Mark Monteforte,Janice Kaczmarek,Vivian Coates,George R. Bailie,Bryan N. Becker,Gavin J. Becker,Jerrilynn D. Burrowes,Fernando Carrera,David N. Churchill,Allan J. Collins,Peter W. Crooks,Dick DeZeeuw,Thomas A. Golper,Frank A. Gotch,Antonio M. Gotto,Roger Greenwood,Joel W. Greer,Richard H. Grimm,William E. Haley,Ronald J. Hogg,Alan R. Hull,Lawrence G. Hunsicker,Cynda Ann Johnson,Michael J. Klag,Saulo Klahr,Norbert Lameire,Francesco Locatelli,Sally McCulloch,Maureen Michael,Joseph V. Nally,John M. Newmann,Allen R. Nissenson,Keith C. Norris,Gregorio T. Obrador,William F. Owen,Thakor G. Patel,Glenda Payne,Claudio Ronco,Rosa A. Rivera-Mizzoni,Anton C. Schoolwerth,Robert A. Star,Michael W. Steffes,Theodore I. Steinman,John Pierre Wauters,Nanette K. Wenger,Josephine P. Briggs,Thomas H. Hostetter,Garabed Eknoyan,Aderra Levin,Nathan W. Levin,Sharon Andreoli,Sally Burrows-Hudson,Derrick Latos,Donna Mapes,Edith Oberley,Brian J.G. Pereira,Nadine Ferguson,Donna Fingerhut,Anthony Gucciardo,Margaret Klette,Doreen Mallard,Kerry Willis +80 more
Reads0
Chats0
About:
This article is published in American Journal of Kidney Diseases.The article was published on 2003-10-01 and is currently open access. It has received 2609 citations till now. The article focuses on the topics: Chronic kidney disease-mineral and bone disorder & Kidney disease.read more
Citations
More filters
Journal ArticleDOI
Calcimimetics and the Treatment of Primary and Secondary Hyperparathyroidism
TL;DR: Cinacalcet has a unique mechanism for reducing PTH concentration and appears to be a safe and effective oral therapy for both primary and secondary HPT.
Journal ArticleDOI
Bone Loss and Fracture Risk Associated with Thiazolidinedione Therapy
Daniel M. Riche,S. Travis King +1 more
TL;DR: Clinicians must take an active role in educating colleagues on the importance of screening thiazolidinedione‐treated patients for fracture risk, counseling patients on adequate calcium and vitamin D intake and fall prevention, and appropriately selecting therapy for secondary prevention of fracture.
Journal ArticleDOI
Influence of Nephrologist Care on Management and Outcomes in Adults with Chronic Kidney Disease
Ana C. Ricardo,Jason Roy,Kaixiang Tao,Arnold B. Alper,Jing Chen,Paul E. Drawz,Jeffrey C. Fink,Chi-yuan Hsu,John W. Kusek,Akinlolu O. Ojo,Martin J. Schreiber,Michael J. Fischer,Michael J. Fischer +12 more
TL;DR: While prior nephrology care was associated with more frequent treatment of CKD complications and use of ACEi/ARB medications, there was neither an association between this care and achievement of guideline-recommended intermediate measures, nor long-term adverse outcomes.
Journal ArticleDOI
Vitamin D Deficiency in Kidney Transplant Recipients: Risk Factors and Effects of Vitamin D3 Supplements
Roberto Marcén,Belen Ponte,Nuria Rodríguez-Mendiola,Ana Fernández-Rodríguez,Cristina Galeano,Juan José Villafruela,José L. Teruel,F.J. Burgos,Joaquín Ortuño +8 more
TL;DR: 25OHD deficiency or insufficiency is frequent after renal transplantation even in sunny regions, and the clinical significance of such a high prevalence is unclear and requires further study.
Journal ArticleDOI
Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.
Masafumi Fukagawa,Hirotaka Komaba,Yoshihiro Onishi,Shunichi Fukuhara,Tadao Akizawa,Kiyoshi Kurokawa +5 more
TL;DR: The severity of SHPT and the use of dialysate with higher calcium concentration are associated with practical difficulty in managing mineral metabolism in dialysis patients.
References
More filters
Journal ArticleDOI
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Geoffrey A. Block,Kevin J. Martin,Angel L.M. de Francisco,Stewart A. Turner,Morrell M. Avram,Michael Suranyi,Gavril Hercz,John Cunningham,Ali K. Abu-Alfa,Piergiorgio Messa,Daniel W. Coyne,Francesco Locatelli,Raphael M. Cohen,Pieter Evenepoel,Sharon M. Moe,Albert Fournier,Johann Braun,Laura C. McCary,Valter J. Zani,Kurt Olson,Tilman B. Drüeke,William G. Goodman +21 more
TL;DR: Cinacalcet lowers parathyroid hormone levels and improves calcium-phosphorus homeostasis in patients receiving hemodialysis who have uncontrolled secondary hyperparathyroidism.